Researchers report that a novel drug combination reduced tumor volume four-fold more than chemotherapy in an animal model of triple negative breast cancer.
As the largest academic cancer center in South Carolina, the MUSC Hollings Cancer Center (HCC) is the state's only National Cancer Institute (NCI)-designated cancer center and one of only 69 NCI centers in the U.S. As an integral component of the Hollings Cancer Center, the MUSC Division of Hematology & Oncology builds upon a long history of excellence in hematology and hematological malignancies, as well as solid tumor oncology and bone marrow transplant. Division faculty are leaders in the fields of cancer care and blood disorders. In the latest rankings by U.S. News & World Report, MUSC Health's Hematology/Oncology program ranked as one of the country's top programs (#32) for the treatment of cancer.
The Division’s fellowship program continues to recruit top tier candidates and is the only hematology oncology training program in the state of South Carolina. The program provides each fellow extensive clinical training in outpatient, inpatient, and consultative medical oncology and benign and malignant hematology, including autologous and allogeneic stem cell transplantation.
The Division's faculty members are equally committed to research and lead efforts in the laboratory as well as conduct clinical trials. Our comprehensive treatment protocols include an ever-expanding clinical trials portfolio offering studies for most types of cancer and blood disorders. As an NCI-Designated Cancer Center, Hollings offers clinical trials and therapies not available elsewhere in South Carolina.
The Division specializes in a wide range of malignant diseases and blood disorders and serves as a statewide referral center for solid tumor oncology, malignant and benign hematology, and bone marrow transplant. The Division's faculty is heavily engaged in numerous multidisciplinary tumor boards and clinics at the University, ensuring that clinicians are able to collaborate across disciplines on patient care and allowing many patients with malignancies to see all of their physicians in one appointment.
Press Ganey announced November 12 the recipients of five prestigious awards - with the Blood and Marrow Transplant Program at the Medical University of South Carolina (MUSC) receiving the Team of the Year award from a pool of 60 Applicants.